Kodiak Sciences Inc (FRA:K27)
€ 3.546 0.072 (2.07%) Market Cap: 211.94 Mil Enterprise Value: 80.00 Mil PE Ratio: 0 PB Ratio: 0.96 GF Score: 37/100

Kodiak Sciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 07:15PM GMT
Release Date Price: €59 (-7.81%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Thanks, everyone, and welcome to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama, I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Priyanka Grover, Malcolm Kuno and Caleb Smith from the team. Our next presenting company is Kodiak and presenting on behalf of the company, we have CEO, Victor Perlroth. I just want to remind all the attendees that there is an ask-a-question feature in the portal. If you would like to put a question in there, I would be happy to ask on your behalf.

With that, Victor, go ahead. Take it away.

Victor Perlroth
Kodiak Sciences Inc. - Co-Founder, Chairman, CEO & President

Thanks, Anupam. Hello, everyone. I'm Victor Perlroth, the CEO of Kodiak. I will be running through our presentation, which is posted on the Kodiak website. So first, we'll just do a quick reminder of the forward-looking statements. So please read those carefully and we'll be describing potential future events that we anticipate.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot